MedPath

Endoscopic Tri-Modal Imaging (ETMI) for the detection of early neoplasia in patients with Barrett*s esophagus (BE) in tertiary referral centers; a randomized cross-over multi-center study.

Completed
Conditions
Barrett's esophagus
esophageal cancer
10017990
Registration Number
NL-OMON30430
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
31
Inclusion Criteria

Age >18 years
Prior diagnosis of Barrett's esophagus
Minimum Barrett's length of C>2M>2 or C<2M>4 according to the Prague C&M classification
Written informed consent

Exclusion Criteria

Presence of esophagitis > grade A according to the LA classification of erosive esophagitis
Presence of conditions precluding histological sampling of the esophagus

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Number of patients detected with dysplasia.<br /><br>Number of lesions detected with dysplasia.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Positive predictive value of high-resolution white light endoscopy and<br /><br>autofluorescence imaging.<br /><br>Reduction of fals-positive findingfs with narrow band imaging.</p><br>
© Copyright 2025. All Rights Reserved by MedPath